All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BNT3214PM8102Phase 21 trial

    BioNTech SE · Advanced Solid Tumor Cancer

  • BNT329Phase 21 trial

    BioNTech SE · Advanced Solid Cancers

  • BO-112Phase 21 trial

    Highlight Therapeutics · Basal Cell Carcinoma

  • BosmolisibBR101801Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Peripheral T Cell Lymphoma

  • BP1001Phase 21 trial

    Bio-Path Holdings, Inc. · Acute Myeloid Leukemia (AML)

  • BPC-2001KRN-7000Phase 21 trial

    BioPhoenix Co., Ltd. · Graft -Versus-host-disease, aGVHD, Haploidentical Stem Cell Transplantation

  • BPI-361175Phase 21 trial

    Xcovery Holdings, Inc. · Non-small Cell Lung Carcinoma

  • BPI-572270Phase 21 trial

    Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)

  • BPM31510Phase 21 trial

    BPGbio · Glioblastoma, Glioblastoma Multiforme

  • BPR-6023021Phase 21 trial

    Chengdu Syncor Pharmaceutical Co., Ltd. · Metastatic Solid Tumors

  • BR1400-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-2Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-3Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-4Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-5Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-APhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-BPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-CPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR2251Phase 21 trial

    BioRay Pharmaceutical Co., Ltd. · Gout and Hyperuricemia

  • BR5402APhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402A-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402BPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402B-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402CPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402C-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402DPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BR5402D-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Schizophrenia

  • BriquilimabJSP191Phase 21 trial

    Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria

  • BRL-101Phase 21 trial

    Bioray Laboratories · Beta-Thalassemia

  • BRM421Phase 21 trial

    BRIM Biotechnology Inc. · Dry Eye Disease (DED), Keratoconjunctivitis Sicca

  • BRTX-100Phase 21 trial

    BioRestorative Therapies · Lumbar Disc Disease

  • BRX011Phase 21 trial

    Biojiva LLC · Geographic Atrophy

  • BRY812Phase 21 trial

    BioRay Pharmaceutical Co., Ltd. · Advanced Gynecological Malignancies

  • BS006Phase 21 trial

    Binhui Biopharmaceutical Co., Ltd. · Solid Tumor

  • BT02Phase 21 trial

    Biotroy Therapeutics · Relapsed or Refractory Hematologic Malignancies, Leukemia, Lymphoma

  • BTV100Phase 21 trial

    BioTheraVision, Inc. · Dry Eye

  • BTZ-043Phase 21 trial

    GSK · Tuberculosis

  • BW-00112Phase 21 trial

    Shanghai Argo Biopharmaceutical Co., Ltd. · Mixed Dyslipidemia

  • BW-20805Phase 21 trial

    Shanghai Argo Biopharmaceutical Co., Ltd. · Hereditary Angioedema (HAE)

  • BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial

    BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)

  • BXQ-350SapC-DOPSPhase 21 trial

    Bexion Pharmaceuticals, Inc. · Metastatic Colorectal Carcinoma, Neuropathy

  • BZ371APhase 21 trial

    Biozeus Biopharmaceutical S.A. · Female Sexual Arousal Disorder, Female Sexual Dysfunction (FSD)

  • C019199Phase 21 trial

    Fujian Haixi Pharmaceuticals Co., Ltd. · Solid Tumor

  • CAL02Phase 21 trial

    Eagle Pharmaceuticals, Inc. · Pneumonia, Bacterial

  • CAL101Phase 21 trial

    Calluna Pharma AS · Idiopathic Pulmonary Fibrosis

  • CAN016Phase 21 trial

    Canwell Biotech Limited · Patients With Advanced Solid Tumors

  • CAP256V2LSPhase 21 trial

    Gilead Sciences · HIV-1-infection

  • CART84Phase 21 trial

    Gyala Therapeutics · Acute Myeloblastic Leukaemia, Leukemia, T-Cell

  • CasdozokitugCHS-388Phase 21 trial

    Coherus Oncology, Inc. · Hepatocellular Carcinoma

  • CB03-154Phase 21 trial

    Shanghai Zhimeng Biopharma, Inc. · Focal Epilepsy

NewerPage 48 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.